COVID-19 Resources and Services from WCG:
COVID-19 Webinar Series
Watch the WCG COVID-19 Webinar Series On-Demand
Join thousands of your peers in watching WCG’s webinar series, where clinical trial and public health experts provide the insights on COVID-19 and discuss the biggest questions and topics you submit.
COVID-19 Trial Insights from the WCG Knowledge Base™
About WCG Trial Insights
The WCG Trial Insights series brings you weekly insights on trial activity throughout the COVID-19 crisis, based on the extensive services we provide to life science clients and supported by our proprietary and powerful WCG Knowledge Base™.
WCG COVID-19 Advisory Services
Need help interpreting critical data to navigate the impact of COVID-19 on trials and sites? We leverage insights and benchmark data from the WCG Knowledge Base to guide best practices for trial performance during this unprecedented time.
Insights from June 11, 2021
Recent Insights from WCG
Watch Recent COVID-19 Webinars
Recent news on COVID-19 and clinical trials
News provided by WCG FDAnews and WCG CenterWatch
Pfizer-BioNTech and Moderna Seek EUAs for Pediatric Omicron-Adapted COVID-19 Shots
Moderna also plans to file an emergency use application for children aged six months to under six years.
Navigo and Mannin Ink Deal to Develop COVID-19 Treatment
The financial terms of the deal were not disclosed.
FDA Expands EUA for Rheonix’s COVID-19 MDx Assay
The company plans to expand the use of the home collection kit through partnerships with other authorized laboratories.
Pfizer to Supply Up to Six Million Paxlovid Treatment Courses to Global Fund
Paxlovid is currently FDA-authorized for treatment of mild-to-moderate COVID-19 in adults and pediatric patients 12 years of age and older weighing at least 40 kg.
Comirnaty and Spikevax Recommended by CHMP for Standard Authorization
The EMA said it will continue to assess any new data on the two vaccines and will take action to protect patients if needed.
Midge Medical Receives CE-IVD Mark for Minoo Test System
The company plans to introduce this system to the German market in the fourth quarter of this year.
WHO Updates Guidelines to Reject Two COVID-19 Antibody Therapies
The panel concluded that the absence of in vitro neutralization activity strongly suggests absence of clinical effectiveness of these monoclonal antibodies.
DiaSorin Gets 510(k) Clearance for Simplexa COVID-19 Test
The development of the product was funded by HHS’ Administration for Strategic Preparedness and Response as well as the Biomedical Advanced Research and Development Authority.
MagBio Receives 510(k) Clearance and CE Mark for MagXtract Collection Tube
The product is the first guanidine-free molecular transport medium, FDA-cleared device available in the U.S.
IMHE Modeling Shows 307 Percent Increase in Long COVID Cases From 2020 to 2021
Nearly 145 million people worldwide experienced symptoms during that timeframe.
EMA’s CHMP Recommends Pfizer and BioNTech’s Adapted Comirnaty Vaccine
Clinical studies with Comirnaty Original/Omicron BA.4-5 are ongoing.
Updated Pfizer-BioNTech and Moderna COVID-19 Boosters Expected Within Days
With these new EUAs in place, FDA has decided to no longer authorize the monovalent mRNA COVID-19 booster doses.
Expert insights on clinical trials and COVID-19
As we navigate COVID-19 together, our clinical trial experts are engaged to address the biggest questions. To submit a topic or question, use the form at the bottom of the page.
Submit a COVID-19 question or topic to be considered in future webinars
Please note: protocol-specific questions for studies under the oversight of a WCG IRB should be submitted through your IRB contact person, not through this form.
Disclaimer: All information available on this site is intended for your general knowledge and is not for the purpose of providing regulatory advice, medical advice, or a substitute for institutional review board review. You should not use this information to determine compliance with any applicable laws or regulations governing institutional review boards and human subjects research.